Jump Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Jump Financial’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$168K	Buy	+39,964	New	+$154K	﹤0.01%	1870
2026 Q1	–	Sell	-10,062	Closed	-$33.9K	–	2136
2025 Q4	$33.9K	Buy	+10,062	New	+$26.1K	﹤0.01%	1880
2024 Q4	–	Sell	-66,189	Closed	-$273K	–	1820
2024 Q3	$273K	Buy	+66,189	New	+$356K	0.01%	1351
2024 Q1	–	Sell	-33,963	Closed	-$389K	–	2083
2023 Q4	$389K	Buy	+33,963	New	+$336K	0.01%	1199
2023 Q3	–	Sell	-15,989	Closed	-$170K	–	2040
2023 Q2	$170K	Sell	15,989 -78,184	-83%	-$840K	0.01%	1549
2023 Q1	$991K	Sell	94,173 -24,791	-21%	-$278K	0.04%	602
2022 Q4	$1.47M	Buy	118,964 +104,220	+707%	+$1.18M	0.08%	338
2022 Q3	$153K	Buy	+14,744	New	+$167K	0.01%	1394
2022 Q2	–	Sell	-92,587	Closed	-$1.16M	–	1810
2022 Q1	$1.16M	Buy	+92,587	New	+$1.06M	0.05%	470
2021 Q4	–	Sell	-71,800	Closed	-$938K	–	1547
2021 Q3	$938K	Sell	71,800 -134,500	-65%	-$1.74M	0.07%	305
2021 Q2	$2.65M	Buy	206,300 +185,300	+882%	+$2.12M	0.26%	58
2021 Q1	$235K	Buy	+21,000	New	+$222K	0.02%	710

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jump Financial's IRWD Position: Q2 2026 in Review

Jump Financial opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2026: 39,964 shares worth $168K. The stake represents ﹤0.01% of the portfolio and ranks #1870 among its holdings. This is a return to the name: Jump Financial previously reported a position in IRWD as recently as Q4 2025.

Jump Financial first reported a position in IRWD in Q1 2021 and has held it in 12 quarters since. The position peaked at $2.65M in Q2 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Jump Financial held 39,964 shares of Ironwood Pharmaceuticals worth $168K as of Q2 2026.
Ironwood Pharmaceuticals was a new Jump Financial position in Q2 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1870 holding.
Jump Financial first reported a position in Ironwood Pharmaceuticals in Q1 2021 and has held it in 12 quarters since.
Jump Financial's Ironwood Pharmaceuticals position peaked at $2.65M in Q2 2021.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.